Penatalaksanaan Psoriasis Terkini

Authors

  • M. Mimbar Topik Universitas Malikussaleh
  • Nabila Tacha Universitas Malikussaleh

DOI:

https://doi.org/10.55606/jikki.v3i3.2166

Keywords:

Treatment, Psoriasis

Abstract

Psoriasis is a chronic skin inflammation with a strong genetic basis. In the skin of psoriasis patients, there are changes in the growth and differentiation of epidermal cells. The term psoriasis comes from the Greek 'psora' which means itching. Psoriasis is a chronic skin inflammation characterized by well-defined erythematous plaques, rough scales, layers and silvery white in color, especially on the elbows, knees, scalp, back, umbilicus and lumbar. Initially psoriasis was thought to be a disease of abnormal proliferation and differentiation of keratinocytes. Psoriasis precipitating factors can vary, including infection, topical irritant agents, and systemic steroids. Precipitating factors are usually involved in the initial manifestation of psoriasis or lead to an exacerbation of the disease. Psoriasis is currently known to have a close relationship with comorbidities such as psoriatic arthritis, obesity, cardiovascular disease, non-alcoholic liver disease, metabolic syndrome, and inflammatory bowel disease that can worsen quality of life and reduce patient life expectancy.

References

Aprilliana, K. F. and Mutiara, H. (2017) Psoriasis Vulgaris pada Laki-laki 46 Tahun.

Budianti, W. K. et al. (2019) ‘Kesesuaian Tata Laksana Psoriasis dengan Panduan Praktik Klinis (PPK) Di RSUPN Dr. Cipto Mangunkusumo’, Media Dermato Venereologica Indonesiana, 46(4), pp. 172–177. doi: 10.33820/mdvi.v46i4.77.

Damayanti, K. D. P. (2018) ‘Profil Psoriasis Vulgaris di RSUD Dr . Soetomo Surabaya: Studi Retropektif’, Berkala Ilmu Kesehatan Kulit dan Kelamin – Periodical of Dermatology and Venereology, 30(3), pp. 248–254.

Dewi, F. D. K. (2021) ‘Terapi pada Psoriasis’, Jurnal Medika Hutama, 02(02), pp. 631–641.

Djuanda, A., Hamzah, M. and Aisah, S. (2010) Ilmu Penyakit Kulit dan Kelamin. 6th edn. Jakarta: Badan Penerbit FKUI.

Habashy, J. (2021) Psoriasis: Practice Essentials, Background, Pathophysiology, Medscape.

Oakley, A. (2017) Dermatology Made Easy. DermNet New Zealand.

Rahayu, F. M. (2020) ‘Psoriasis Inversa: Laporan Kasus’, pp. 93–98.

Rendon, A. and Schäkel, K. (2019) ‘Psoriasis Pathogenesis and Treatment’, International Journal of Molecular Sciences, 20(6), pp. 1–28. doi: 10.3390/ijms20061475.

Sutanto, N. R. and Budianti, W. K. (2021) ‘Perkembangan Terkini Terapi Sistemik Psoriasis Current Systemic Therapy for Psoriasis’, J Kdokt Meditek, 27(2), pp. 136–146.

Waworuntu, G., Tanjung, C. and Mahadi, I. D. R. (2017) ‘Profil Kadar Vascular Endothelial Growth Factor (VEGF) Serum Berdasarkan Karakteristik Pasien Psoriasis Vulgaris Levels of Serum Vascular Endothelial Growth Factor (VEGF) Based on the Characteristics of Psoriasis Vulgaris Patients Profile’, Media Dermto-Venerologic Indonesiana, 44(14), pp. 8–14.

Widaty, S. et al. (2017) Panduan Praktik Klinik Bagi Dokter Spesialis Kulit dan Kelamin di Indonesia, Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia (PERDOSKI). Jakarta. doi: 10.1021/jo900140t.

World Health Organization (2016) Global Report on Psoriasis.

Yuliastuti, D. (2015) ‘Tinjauan Pustaka Psoriasis’, Cdk-235, 42(12), pp. 901–906.

Downloads

Published

2023-11-30

How to Cite

M. Mimbar Topik, & Nabila Tacha. (2023). Penatalaksanaan Psoriasis Terkini. Jurnal Ilmu Kedokteran Dan Kesehatan Indonesia, 3(3), 134–156. https://doi.org/10.55606/jikki.v3i3.2166

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.